Mary L. Legerski, Director, Corporate Compliance, Cleveland Clinic. Vicki Bokar, Senior Director, Corporate Compliance, Cleveland Clinic.
March 30, 2020
Learn how to operationalize key provisions of 42 CFR part 2 Confidentiality of Substance Use Disorder Patient Records including the following: Obtaining patient consent, sharing information for health information exchanges, etc.
Identify substance abuse records that may be accessible in your electronic health record system that you haven’t even thought about
Learn how to engage information technology staff and business associates to assist the compliance team in implementing necessary controls and processes for Part 2 compliance which may differ from the controls and processes already in place for HIPAA
THIS DOCUMENT IS ONLY AVAILABLE TO MEMBERS OR ATTENDEES. PLEASE LOG IN OR PURCHASE ACCESS.